Literature DB >> 27895008

De Novo Emergence of Genetically Resistant Mutants of Mycobacterium tuberculosis from the Persistence Phase Cells Formed against Antituberculosis Drugs In Vitro.

Jees Sebastian1, Sharmada Swaminath1, Rashmi Ravindran Nair1, Kishor Jakkala1, Atul Pradhan1, Parthasarathi Ajitkumar2.   

Abstract

Bacterial persisters are a subpopulation of cells that can tolerate lethal concentrations of antibiotics. However, the possibility of the emergence of genetically resistant mutants from antibiotic persister cell populations, upon continued exposure to lethal concentrations of antibiotics, remained unexplored. In the present study, we found that Mycobacterium tuberculosis cells exposed continuously to lethal concentrations of rifampin (RIF) or moxifloxacin (MXF) for prolonged durations showed killing, RIF/MXF persistence, and regrowth phases. RIF-resistant or MXF-resistant mutants carrying clinically relevant mutations in the rpoB or gyrA gene, respectively, were found to emerge at high frequency from the RIF persistence phase population. A Luria-Delbruck fluctuation experiment using RIF-exposed M. tuberculosis cells showed that the rpoB mutants were not preexistent in the population but were formed de novo from the RIF persistence phase population. The RIF persistence phase M. tuberculosis cells carried elevated levels of hydroxyl radical that inflicted extensive genome-wide mutations, generating RIF-resistant mutants. Consistent with the elevated levels of hydroxyl radical-mediated genome-wide random mutagenesis, MXF-resistant M. tuberculosis gyrA de novo mutants could be selected from the RIF persistence phase cells. Thus, unlike previous studies, which showed emergence of genetically resistant mutants upon exposure of bacteria for short durations to sublethal concentrations of antibiotics, our study demonstrates that continuous prolonged exposure of M. tuberculosis cells to lethal concentrations of an antibiotic generates antibiotic persistence phase cells that form a reservoir for the generation of genetically resistant mutants to the same antibiotic or another antibiotic. These findings may have clinical significance in the emergence of drug-resistant tubercle bacilli.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  Mycobacterium tuberculosis; antibiotic resistance; hydroxyl radical; moxifloxacin; persistence phase cells; rifampicin

Mesh:

Substances:

Year:  2017        PMID: 27895008      PMCID: PMC5278719          DOI: 10.1128/AAC.01343-16

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  105 in total

1.  Bacterial persistence as a phenotypic switch.

Authors:  Nathalie Q Balaban; Jack Merrin; Remy Chait; Lukasz Kowalik; Stanislas Leibler
Journal:  Science       Date:  2004-08-12       Impact factor: 47.728

2.  Eradication of bacterial persisters with antibiotic-generated hydroxyl radicals.

Authors:  Sarah Schmidt Grant; Benjamin B Kaufmann; Nikhilesh S Chand; Nathan Haseley; Deborah T Hung
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-09       Impact factor: 11.205

3.  On the mechanism of OH. scavenger action.

Authors:  B Tadolini; L Cabrini
Journal:  Biochem J       Date:  1988-08-01       Impact factor: 3.857

4.  Development of novel fluorescence probes that can reliably detect reactive oxygen species and distinguish specific species.

Authors:  Ken-ichi Setsukinai; Yasuteru Urano; Katsuko Kakinuma; Hideyuki J Majima; Tetsuo Nagano
Journal:  J Biol Chem       Date:  2002-11-04       Impact factor: 5.157

5.  The competitive cost of antibiotic resistance in Mycobacterium tuberculosis.

Authors:  Sebastien Gagneux; Clara Davis Long; Peter M Small; Tran Van; Gary K Schoolnik; Brendan J M Bohannan
Journal:  Science       Date:  2006-06-30       Impact factor: 47.728

6.  Rifampicin resistance and mutation of the rpoB gene in Mycobacterium tuberculosis.

Authors:  H Taniguchi; H Aramaki; Y Nikaido; Y Mizuguchi; M Nakamura; T Koga; S Yoshida
Journal:  FEMS Microbiol Lett       Date:  1996-10-15       Impact factor: 2.742

7.  Detection of mRNA transcripts and active transcription in persistent Mycobacterium tuberculosis induced by exposure to rifampin or pyrazinamide.

Authors:  Y Hu; J A Mangan; J Dhillon; K M Sole; D A Mitchison; P D Butcher; A R Coates
Journal:  J Bacteriol       Date:  2000-11       Impact factor: 3.490

Review 8.  Cellular defenses against superoxide and hydrogen peroxide.

Authors:  James A Imlay
Journal:  Annu Rev Biochem       Date:  2008       Impact factor: 23.643

9.  Location of persisting mycobacteria in a Guinea pig model of tuberculosis revealed by r207910.

Authors:  Anne J Lenaerts; Donald Hoff; Sahar Aly; Stefan Ehlers; Koen Andries; Luis Cantarero; Ian M Orme; Randall J Basaraba
Journal:  Antimicrob Agents Chemother       Date:  2007-05-21       Impact factor: 5.191

10.  Location of intra- and extracellular M. tuberculosis populations in lungs of mice and guinea pigs during disease progression and after drug treatment.

Authors:  Donald R Hoff; Gavin J Ryan; Emily R Driver; Cornelius C Ssemakulu; Mary A De Groote; Randall J Basaraba; Anne J Lenaerts
Journal:  PLoS One       Date:  2011-03-21       Impact factor: 3.240

View more
  35 in total

Review 1.  Experimental Design, Population Dynamics, and Diversity in Microbial Experimental Evolution.

Authors:  Bram Van den Bergh; Toon Swings; Maarten Fauvart; Jan Michiels
Journal:  Microbiol Mol Biol Rev       Date:  2018-07-25       Impact factor: 11.056

2.  Vitamin C Potentiates the Killing of Mycobacterium tuberculosis by the First-Line Tuberculosis Drugs Isoniazid and Rifampin in Mice.

Authors:  Catherine Vilchèze; John Kim; William R Jacobs
Journal:  Antimicrob Agents Chemother       Date:  2018-02-23       Impact factor: 5.191

3.  Preexisting variation in DNA damage response predicts the fate of single mycobacteria under stress.

Authors:  Giulia Manina; Anna Griego; Lalit Kumar Singh; John D McKinney; Neeraj Dhar
Journal:  EMBO J       Date:  2019-10-04       Impact factor: 11.598

Review 4.  The Isoniazid Paradigm of Killing, Resistance, and Persistence in Mycobacterium tuberculosis.

Authors:  Catherine Vilchèze; William R Jacobs
Journal:  J Mol Biol       Date:  2019-02-21       Impact factor: 5.469

Review 5.  Biology of antimicrobial resistance and approaches to combat it.

Authors:  Sarah M Schrader; Julien Vaubourgeix; Carl Nathan
Journal:  Sci Transl Med       Date:  2020-06-24       Impact factor: 17.956

6.  Enhancement of the Bactericidal Effect of Antibiotics by Inhibition of Enzymes Involved in Production of Hydrogen Sulfide in Bacteria.

Authors:  T A Seregina; K V Lobanov; R S Shakulov; A S Mironov
Journal:  Mol Biol       Date:  2022-10-05       Impact factor: 1.540

7.  The Error-Prone Polymerase DnaE2 Mediates the Evolution of Antibiotic Resistance in Persister Mycobacterial Cells.

Authors:  S Salini; Sinchana G Bhat; Saba Naz; Ramanathan Natesh; R Ajay Kumar; Vinay Kumar Nandicoori; Krishna Kurthkoti
Journal:  Antimicrob Agents Chemother       Date:  2022-03-15       Impact factor: 5.938

Review 8.  In Vivo Imaging with Genetically Encoded Redox Biosensors.

Authors:  Alexander I Kostyuk; Anastasiya S Panova; Aleksandra D Kokova; Daria A Kotova; Dmitry I Maltsev; Oleg V Podgorny; Vsevolod V Belousov; Dmitry S Bilan
Journal:  Int J Mol Sci       Date:  2020-10-31       Impact factor: 5.923

9.  Enhanced Antibacterial Activity of Repurposed Mitomycin C and Imipenem in Combination with the Lytic Phage vB_KpnM-VAC13 against Clinical Isolates of Klebsiella pneumoniae.

Authors:  Olga Pacios; Laura Fernández-García; Ines Bleriot; Lucía Blasco; Mónica González-Bardanca; María López; Felipe Fernández-Cuenca; Jesús Oteo; Álvaro Pascual; Luis Martínez-Martínez; Pilar Domingo-Calap; Germán Bou; María Tomás
Journal:  Antimicrob Agents Chemother       Date:  2021-08-17       Impact factor: 5.191

Review 10.  Understanding the Reciprocal Interplay Between Antibiotics and Host Immune System: How Can We Improve the Anti-Mycobacterial Activity of Current Drugs to Better Control Tuberculosis?

Authors:  Hyun-Eui Park; Wonsik Lee; Min-Kyoung Shin; Sung Jae Shin
Journal:  Front Immunol       Date:  2021-06-28       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.